Subtopic Deep Dive
Folate Vitamin B12 and Neural Tube Defects
Research Guide
What is Folate Vitamin B12 and Neural Tube Defects?
Folate Vitamin B12 and Neural Tube Defects investigates maternal folate and vitamin B12 status, MTHFR polymorphisms, and one-carbon metabolism disruptions in neural tube defect etiology through metabolic studies and fortification trials.
Neural tube defects (NTDs) like spina bifida and anencephaly arise from incomplete neural tube closure during embryogenesis. Low maternal plasma folate and B12 independently elevate NTD risk (Kirke et al., 1993, 506 citations). Fortification with 0.4 mg folic acid daily reduces NTD cases by over 50% (1992 Recommendations, 930 citations). Over 10 key papers from provided list exceed 500 citations each.
Why It Matters
Mandatory folic acid fortification in the US and 80+ countries cut NTD prevalence by 20-78% post-implementation (Crider et al., 2011). Residual risks persist due to MTHFR C677T polymorphism reducing enzyme activity by 30-70%, elevating homocysteine and NTD odds (Botto and Yang, 2000). B12 deficiency compounds folate insufficiency in one-carbon metabolism, critical for DNA synthesis during neural tube closure (Kirke et al., 1993). Personalized screening for folate/B12 and MTHFR variants guides high-risk pregnancies, preventing 50-70% of cases via targeted supplementation (Daly, 1995). Public health programs saved thousands of births annually, but gaps remain in low-B12 regions.
Key Research Challenges
MTHFR Polymorphism Interactions
MTHFR C677T and A1298C alleles impair folate conversion to 5-methylTHF, raising homocysteine and NTD risk variably by ethnicity. Interactions with B12 status complicate risk prediction (Botto and Yang, 2000). Dose-response models need refinement for homozygous carriers.
Residual Post-Fortification Risks
NTD rates dropped post-fortification, but 20-50% cases persist due to non-responders and B12 deficiency. Folate-B12 interplay in methionine synthesis requires biomarkers for monitoring (Bailey et al., 2015). Regional dietary gaps hinder uniform efficacy (Crider et al., 2011).
Biomarker Standardization
Plasma folate, red cell folate, and homocysteine assays vary by method, affecting NTD risk thresholds. B12 functional markers like methylmalonic acid improve detection but lack consensus (Refsum et al., 2004). Harmonized cutoffs needed for trials.
Essential Papers
Biomarkers of Nutrition for Development—Folate Review
Lynn B. Bailey, Patrick J. Stover, Helene McNulty et al. · 2015 · Journal of Nutrition · 1.1K citations
5, 10-Methylenetetrahydrofolate Reductase Gene Variants and Congenital Anomalies: A HuGE Review
Lorenzo D. Botto, Quanhe Yang · 2000 · American Journal of Epidemiology · 1.0K citations
The enzyme 5,10-methylenetetrahydrofolate reductase (MTHFR) is involved in folate metabolism. The MTHFR gene is located on chromosome 1 (1p36.3), and two common alleles, the C677T (thermolabile) al...
Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion
Helga Refsum, A. David Smith, Per Magne Ueland et al. · 2004 · Clinical Chemistry · 1.0K citations
Abstract Background: Measurement of plasma total homocysteine has become common as new methods have been introduced. A wide range of disorders are associated with increased concentrations of total ...
Choline: an essential nutrient for public health
Steven H. Zeisel, Kerry-Ann da Costa · 2009 · Nutrition Reviews · 1.0K citations
Choline was officially recognized as an essential nutrient by the Institute of Medicine (IOM) in 1998. There is significant variation in the dietary requirement for choline that can be explained by...
Recommendations for the Use of Folic Acid to Reduce the Number of Cases of Spina Bifida and Other Neural Tube Defects
· 1992 · PsycEXTRA Dataset · 930 citations
Spina bifida and anencephaly are common and serious birth defects. Available evidence indicates that 0.4 mg (400 micrograms) per day of folic acid, one of the B vitamins, will reduce the number of ...
Folate Levels and Neural Tube Defects
Leslie Daly · 1995 · JAMA · 752 citations
Using data from a recent case-control study, a woman's risk of having a child with a neural tube defect (NTD) was found to be associated with early pregnancy red cell folate levels in a continuous ...
Neural Tube Defects
Nicholas D. E. Greene, Andrew J. Copp · 2014 · Annual Review of Neuroscience · 620 citations
Neural tube defects (NTDs), including spina bifida and anencephaly, are severe birth defects of the central nervous system that originate during embryonic development when the neural tube fails to ...
Reading Guide
Foundational Papers
Start with 1992 Recommendations (930 citations) for folic acid dosing evidence; Kirke et al. (1993, 506 citations) for B12-folate risk factors; Botto and Yang (2000, 1045 citations) for MTHFR genetics basics.
Recent Advances
Bailey et al. (2015, 1094 citations) for biomarker consensus; Crider et al. (2011, 578 citations) for fortification outcomes; Greene and Copp (2014, 620 citations) for NTD embryology.
Core Methods
Biomarker assays (plasma/red cell folate, homocysteine, MMA); MTHFR genotyping (C677T/A1298C PCR); population trials (periconceptional supplementation, fortification surveillance); dose-response modeling.
How PapersFlow Helps You Research Folate Vitamin B12 and Neural Tube Defects
Discover & Search
Research Agent uses searchPapers and citationGraph to map 10+ high-cite papers like Bailey et al. (2015, 1094 citations) on folate biomarkers, revealing clusters around MTHFR (Botto and Yang, 2000) and fortification (Crider et al., 2011). exaSearch uncovers trial data on B12-folate interactions; findSimilarPapers expands to 50+ related NTD studies.
Analyze & Verify
Analysis Agent applies readPaperContent to extract dose-response curves from Daly (1995), then verifyResponse with CoVe checks MTHFR risk claims against Kirke et al. (1993). runPythonAnalysis plots homocysteine-folate correlations via pandas on extracted data; GRADE grading scores fortification evidence as high-quality (Crider et al., 2011).
Synthesize & Write
Synthesis Agent detects gaps in B12 personalization post-fortification via contradiction flagging across Bailey et al. (2015) and Kirke et al. (1993). Writing Agent uses latexEditText for risk model equations, latexSyncCitations for 20-paper bibliography, and latexCompile for publication-ready review; exportMermaid diagrams one-carbon pathways.
Use Cases
"Analyze folate B12 dose-response for NTD risk in MTHFR carriers"
Research Agent → searchPapers('MTHFR NTD folate B12') → Analysis Agent → runPythonAnalysis(pandas plot Daly 1995 data vs Kirke 1993) → matplotlib graph of odds ratios with statistical verification.
"Draft LaTeX review on fortification efficacy and residual NTD risks"
Synthesis Agent → gap detection (Crider 2011 vs Bailey 2015) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(10 papers) → latexCompile → PDF with mermaid one-carbon metabolism diagram.
"Find code for simulating homocysteine metabolism models"
Research Agent → citationGraph(Refsum 2004) → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → Python scripts for B12-folate kinetic models with NumPy validation.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(50+ NTD folate B12 papers) → citationGraph → GRADE all → structured report on fortification impacts (Crider et al., 2011). DeepScan applies 7-step CoVe chain to verify MTHFR polymorphism effects (Botto and Yang, 2000), checkpointing biomarker claims. Theorizer generates hypotheses on B12-folate synergy from Kirke et al. (1993) and Daly (1995) for trial design.
Frequently Asked Questions
What defines the link between folate, B12, and neural tube defects?
Low maternal plasma folate (<7 nmol/L) and B12 (<185 pmol/L) independently raise NTD odds 4-16 fold via disrupted one-carbon metabolism (Kirke et al., 1993).
What methods study this subtopic?
Case-control studies measure early pregnancy biomarkers; fortification trials track NTD rates; genetic analyses genotype MTHFR C677T/A1298C (Botto and Yang, 2000; Crider et al., 2011).
What are key papers?
Bailey et al. (2015, 1094 citations) reviews folate biomarkers; Kirke et al. (1993, 506 citations) proves B12-folate independence; 1992 Recommendations (930 citations) set 400 mcg/day standard.
What open problems remain?
Optimal B12 dosing for MTHFR carriers; biomarkers for non-responders post-fortification; ethnic-specific risk models integrating homocysteine (Refsum et al., 2004; Bailey et al., 2015).
Research Folate and B Vitamins Research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Folate Vitamin B12 and Neural Tube Defects with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Folate and B Vitamins Research Research Guide